What causes fks

What is Familial Hypercholesterolemia (FH)?

Familial Hypercholesterolemia (FH), sometimes referred to as FKS in certain contexts, is a serious inherited condition that affects how the body processes cholesterol. Cholesterol is a waxy, fat-like substance that is essential for building healthy cells. However, when levels of low-density lipoprotein (LDL) cholesterol, often termed 'bad' cholesterol, become excessively high, it can lead to significant health problems, particularly cardiovascular disease. In FH, the body's ability to clear LDL cholesterol from the bloodstream is severely impaired due to genetic defects.

What Causes Familial Hypercholesterolemia?

The root cause of FH lies in genetic mutations. These mutations are typically inherited from one or both parents and affect the genes responsible for managing LDL cholesterol. The most common genes involved are:

• LDLR gene: This gene provides instructions for making a receptor that binds to LDL cholesterol particles and removes them from the blood. Mutations in LDLR are the most frequent cause of FH.
• APOB gene: This gene provides instructions for making apolipoprotein B, a protein that is a component of LDL cholesterol and helps it bind to the LDLR. Mutations here can impair the binding of LDL to its receptor.
• PCSK9 gene: This gene provides instructions for making a protein that regulates the number of LDLRs on the surface of liver cells. Mutations in PCSK9 can lead to an overproduction of this protein, which in turn causes more LDLRs to be broken down, reducing LDL clearance.
• LDLRAP1 gene: This gene is associated with a rarer form of FH called autosomal recessive hypercholesterolemia. Mutations here affect the internalisation of the LDL receptor complex into the cell.

Inheritance patterns determine the severity of FH:

• Heterozygous FH (HeFH): This is the more common form, occurring when a person inherits one mutated gene from one parent. Individuals with HeFH have one normal copy of the gene and one mutated copy. They typically have LDL cholesterol levels that are about two to four times higher than normal from birth.
• Homozygous FH (HoFH): This is a much rarer and more severe form, occurring when a person inherits two mutated genes, one from each parent. Individuals with HoFH have extremely high LDL cholesterol levels, often ten times higher than normal, from birth. This form can lead to severe cardiovascular problems at a very young age, sometimes even in childhood or adolescence.

How Does FH Lead to Health Problems?

High LDL cholesterol levels, particularly when present from birth and over a lifetime, contribute to the buildup of plaque in the arteries. This process is called atherosclerosis. Over time, this plaque can narrow the arteries, restricting blood flow and increasing the risk of blood clots. If a blood clot blocks an artery supplying the heart, it can cause a heart attack. If it blocks an artery supplying the brain, it can cause a stroke. People with FH are at a significantly elevated risk of experiencing these cardiovascular events at a much earlier age than the general population, often in their 40s or 50s, and sometimes even earlier for those with HoFH.

Diagnosis and Management

FH is often underdiagnosed. Diagnosis typically involves:

• Family history: A detailed family history of high cholesterol or early heart disease is a key indicator.
• Physical examination: Doctors may look for physical signs like xanthelasma (yellowish cholesterol deposits around the eyes) or xanthomas (cholesterol deposits in tendons).
• Blood tests: Measuring LDL cholesterol levels is crucial. Very high levels, especially in the absence of other risk factors, are suggestive of FH. Genetic testing can confirm the diagnosis by identifying specific gene mutations.

Management of FH focuses on lowering LDL cholesterol levels to reduce cardiovascular risk. This typically involves:

• Lifestyle modifications: While lifestyle changes alone are usually insufficient for FH, a heart-healthy diet low in saturated and trans fats, regular exercise, and weight management are still important components of care.
• Medications: Statins are the cornerstone of treatment for FH, often requiring high doses. Other medications may be used in combination, such as ezetimibe, PCSK9 inhibitors (which directly target the PCSK9 protein to increase LDL receptor activity), and in severe cases, bile acid sequestrants or other emerging therapies.
• Cascade screening: Once FH is diagnosed in an individual, it is crucial to screen their close relatives (parents, siblings, children) to identify others who may have the condition and can benefit from early treatment.

Early diagnosis and consistent management are vital for individuals with FH to lead longer, healthier lives and significantly reduce their risk of premature cardiovascular events.